Sign Up Today and Learn More About IASO Biotherapeutics Stock
Invest in or calculate the value of your shares in IASO Biotherapeutics or other pre-IPO companies through EquityZen's platform.
IASO Biotherapeutics Stock (IABI)
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
About IASO Biotherapeutics Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
IASO Biotherapeutics Press Mentions
Stay in the know about the latest news on IASO Biotherapeutics
JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
morningstar • Nov 08, 2024
JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
prnewswire • Nov 08, 2024
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) on LinkedIn: #cellandgenetherapy #cgt
linkedin • Jul 03, 2024
Monoclonal Antibodies: A Transformative Force in ...
prnewswire • Dec 19, 2023
NMPA approval for first BCMA CAR-T paves way for more ...
biopharma-reporter • Dec 19, 2023
IASO Biotherapeutics Management
Leadership team at IASO Biotherapeutics
CEO & CMO
Wen Wang
Co-Founder & Executive Vice President
Brian K. Hall
Join now and verify your accreditation status to gain access to:
- IASO Biotherapeutics current valuation
- IASO Biotherapeutics stock price
- Available deals in IASO Biotherapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in IASO Biotherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like IASO Biotherapeutics through EquityZen funds. These investments are made available by existing IASO Biotherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell IASO Biotherapeutics stock?
Shareholders can sell their IASO Biotherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
